Alfred L. Garfall, MD, discusses long-term follow-up data from the MajesTEC-1 study presented at ASCO 2024. 1. Discuss the data presented at ASCO 2024 on long-term follow-up of patients receiving ...
Please provide your email address to receive an email when new articles are posted on . Among experienced operators, prophylactic nitroglycerin did not prevent radial artery spasm during transradial ...
...and of course by 'prophylactic' I'm referring to a toothbrush.<BR><BR>I just had an encounter with someone using a toothbrush in the restroom here at work. It struck me that I've seen a lot of ...
PTCY offers improved progression-free and overall survival compared to ATG in MDS patients undergoing allo-HSCT. PTCY is associated with lower rates of grade 2 to 4 acute GVHD but has delayed ...
Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients With Nonmetastatic Muscle-Invasive Bladder Cancer: Results of ...
Please provide your email address to receive an email when new articles are posted on . The FDA updated the prescribing information for axicabtagene ciloleucel to allow the use of prophylactic ...
The updated labeling is based on results from a safety management cohort from the ZUMA-1 study. The Food and Drug Administration (FDA) has approved updated labeling for Yescarta ® (axicabtagene ...